Search

Novavax Inc

Slēgts

SektorsVeselības aprūpe

10.09 1.2

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.75

Max

10.14

Galvenie mērījumi

By Trading Economics

Ienākumi

-44M

-53M

Pārdošana

-83M

57M

P/E

Sektora vidējais

3.112

56.432

EPS

-0.32

Peļņas marža

-94.16

Darbinieki

749

EBITDA

-39M

-40M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+12.1% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

363M

1.6B

Iepriekšējā atvēršanas cena

8.89

Iepriekšējā slēgšanas cena

10.09

Ziņu noskaņojums

By Acuity

50%

50%

120 / 339 Rangs Healthcare

Novavax Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 18. sept. 20:06 UTC

Novavax Inc shares are higher in Friday's trading session, recovering from mid-morning lows and maintaining a position above the 20-day moving average.

2026. g. 17. sept. 20:02 UTC

Novavax Inc is advancing, continuing sharp gains since Wednesday, despite earlier pulling back from a session high amid broader market weakness.

2026. g. 16. sept. 23:21 UTC

Novavax Inc's stock is modestly lower in after-market trading, following earlier volatility and currently trading below its 20-day moving average.

2026. g. 15. sept. 22:51 UTC

Novavax Inc. shares are lower in after-market hours, reflecting broader economic concerns following a decline in the NY Empire State Manufacturing Index.

2026. g. 14. sept. 23:36 UTC

Novavax shares are trading lower in after-market hours, following a broader decline in U.S. stocks amid rising crude oil prices and supply concerns.

2026. g. 11. sept. 20:08 UTC

Novavax Inc. shares are higher during Friday's session, having reached a session high earlier before pulling back. No specific news was identified.

2026. g. 10. sept. 23:01 UTC

Novavax Inc. shares are lower in after-market hours, continuing recent downward trends. The stock reached its lowest point shortly after the market reopened.

2026. g. 9. sept. 19:46 UTC

Social Media

Novavax Inc shares are lower amid ongoing volatility following first-quarter results. The stock has faced pressure, dipping below $11.50 earlier in the session.

2026. g. 8. sept. 19:26 UTC

Novavax Inc. shares are trading roughly flat, reflecting minimal change since Friday's close amid broader market trends. The asset remains above its 20-day moving average.

2026. g. 4. sept. 23:15 UTC

Novavax Inc. shares are lower in after-market hours, reflecting a slight decline since Friday's close amid rising Treasury yields and interest rate expectations.

2026. g. 3. sept. 23:05 UTC

Novavax Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average and showing significant gains from a month ago.

2026. g. 2. sept. 23:06 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

2026. g. 1. sept. 23:31 UTC

Novavax Inc. shares are lower in after-market trading, showing volatility since Tuesday's close, though the stock remains well above its 20-day moving average.

2026. g. 31. aug. 23:01 UTC

Novavax Inc shares are higher in after-market trading, continuing a strong three-session performance. No specific news was identified to explain the movement.

2026. g. 28. aug. 23:01 UTC

Novavax Inc shares declined in after-market trading, amid rising market expectations for an interest rate hike and upward pressure on Treasury yields.

2026. g. 27. aug. 23:01 UTC

Novavax Inc. shares are higher in after-market trading, rebounding from earlier volatility and remaining above the 20-day moving average.

2026. g. 26. aug. 20:08 UTC

Novavax Inc shares are lower as the biotechnology sector declines. The stock rebounded earlier in the session but has since pulled back.

2026. g. 25. aug. 20:07 UTC

Novavax Inc shares are higher Tuesday, supported by lower Treasury yields. The stock pulled back from an intraday high but remains up since Monday.

2026. g. 24. aug. 20:04 UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

2026. g. 21. aug. 23:31 UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

2026. g. 20. aug. 19:02 UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

2026. g. 19. aug. 23:51 UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

2026. g. 17. aug. 19:36 UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

2026. g. 14. aug. 23:26 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

2026. g. 13. aug. 19:16 UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

2026. g. 12. aug. 23:31 UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

2026. g. 11. aug. 23:51 UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

2026. g. 10. aug. 23:46 UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

2026. g. 7. aug. 19:36 UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

2026. g. 6. aug. 23:01 UTC

News

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

Salīdzinājums

Cenas izmaiņa

Novavax Inc Prognoze

Cenas mērķis

By TipRanks

12.1% augšup

Prognoze 12 mēnešiem

Vidējais 11.333 USD  12.1%

Augstākais 18 USD

Zemākais 7 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Novavax Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

3 ratings

1

Pirkt

1

Turēt

1

Pārdot

Noskaņojums

By Acuity

120 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.